German
|
English
|
French
Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "R06AA" (17)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Diphenhydramine (R06AA02) 4 products
WHO-DDD
DrugBank.ca
IP
CI
Benocten
20 Tablet(s)
12.90
k.A.
Tablets: Diphenhydramini Hydrochloridum 50 mg
Medinova AG
B
FB
G
IP
CI
Bonox
10
k.A.
Tablets: Diphenhydramini Hydrochloridum 50 mg
Dr. Heinz Welti AG,
Fabrikation chemisch-
pharmazeutischer
Produkte
●
B
FB
G
IP
CI
Bonox
20
k.A.
Tablets: Diphenhydramini Hydrochloridum 50 mg
Dr. Heinz Welti AG,
Fabrikation chemisch-
pharmazeutischer
Produkte
●
B
FB
G
IP
CI
Benocten
20 ml
9.50
k.A.
Tropfen zum Einnehmen: Diphenhydramini Hydrochloridum 60.48 mg/ml
Medinova AG
●
B
FB
G
Clemastine (R06AA04) 2 products
WHO-DDD
DrugBank.ca
IP
CI
Tavegyl
5 ampoule(s)
7.41
17.30
10 %
Injection solution: Clemastinum 2mg / 2ml
Gebro Pharma AG
B / SL
FB
G
IP
CI
Tavegyl
20 Tablet(s)
k.A.
Tablets: Clemastinum 1 mg
Spirig HealthCare AG
D
FB
G
Diphenhydramine, Combinations (R06AA52) 3 products
WHO-DDD
DrugBank.ca
IP
CI
Rhinitin retard
12 Capsule(s)
k.A.
Capsules: 2 Active Agents
Laves-Arzneimittel
Gesellschaft mit
beschränkter Haftung,
Ronnenberg,
Zweigniederlassung
Schötz
D
FB
G
Benylin
160 g
k.A.
Sirup: 2 Active Agents
Pfizer AG
C
FB
G
Benylin
600 g
k.A.
Sirup: 2 Active Agents
Pfizer AG
C
FB
G
Doxylamine, Combinations (R06AA59) 8 products
WHO-DDD
DrugBank.ca
IP
CI
Bonjesta 20 mg / 20 mg
20
28.30
47.20
10 %
Tablette mit veränderter Wirkstofffreisetzung: 2 Active Agents
Exeltis Suisse SA
B / SL
FB
G
IP
CI
Bonjesta 20 mg / 20 mg
40
49.81
70.60
10 %
Tablette mit veränderter Wirkstofffreisetzung: 2 Active Agents
Exeltis Suisse SA
B / SL
FB
G
IP
CI
Cariban 10 mg/10 mg
24
16.98
34.90
10 %
gélule à libération modifiée: 2 Active Agents
Effik SA
B / SL
FB
G
IP
CI
Cariban 10 mg/10 mg
48
29.88
48.90
10 %
gélule à libération modifiée: 2 Active Agents
Effik SA
B / SL
FB
G
IP
CI
Bonjesta 20 mg / 20 mg
10
k.A.
Tablette mit veränderter Wirkstofffreisetzung: 2 Active Agents
Exeltis Suisse SA
B
FB
G
IP
CI
Bonjesta 20 mg / 20 mg
30
k.A.
Tablette mit veränderter Wirkstofffreisetzung: 2 Active Agents
Exeltis Suisse SA
B
FB
G
IP
CI
Bonjesta 20 mg / 20 mg
50
k.A.
Tablette mit veränderter Wirkstofffreisetzung: 2 Active Agents
Exeltis Suisse SA
B
FB
G
IP
CI
Bonjesta 20 mg / 20 mg
60
k.A.
Tablette mit veränderter Wirkstofffreisetzung: 2 Active Agents
Exeltis Suisse SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
